The management team is excited to announce their presence at ESCMID - European Society of Clinical Microbiology and Infectious Diseases, marking SXM's debut to the scientific community with oral and poster presentations, showcasing our commitment to innovation, collaborative research and improving patient outcomes. Connect with (from left to right):
our CEO Dr. Sophia E. Shanko, our CSO Dr. ir. Ardjan van der Linden, our CTO Dr. Henk Stapert and our IVD Strategy Lead Prof. Dr. Dr. Alex van Belkum
